Literature DB >> 25751313

Contribution of Intronic miR-338-3p and Its Hosting Gene AATK to Compensatory β-Cell Mass Expansion.

Cécile Jacovetti1, Veronica Jimenez, Eduard Ayuso, Ross Laybutt, Marie-Line Peyot, Marc Prentki, Fatima Bosch, Romano Regazzi.   

Abstract

The elucidation of the mechanisms directing β-cell mass regeneration and maintenance is of interest, because the deficit of β-cell mass contributes to diabetes onset and progression. We previously found that the level of the microRNA (miRNA) miR-338-3p is decreased in pancreatic islets from rodent models displaying insulin resistance and compensatory β-cell mass expansion, including pregnant rats, diet-induced obese mice, and db/db mice. Transfection of rat islet cells with oligonucleotides that specifically block miR-338-3p activity increased the fraction of proliferating β-cells in vitro and promoted survival under proapoptotic conditions without affecting the capacity of β-cells to release insulin in response to glucose. Here, we evaluated the role of miR-338-3p in vivo by injecting mice with an adeno-associated viral vector permitting specific sequestration of this miRNA in β-cells. We found that the adeno-associated viral construct increased the fraction of proliferating β-cells confirming the data obtained in vitro. miR-338-3p is generated from an intron of the gene coding for apoptosis-associated tyrosine kinase (AATK). Similarly to miR-338-3p, we found that AATK is down-regulated in rat and human islets and INS832/13 β-cells in the presence of the cAMP-raising agents exendin-4, estradiol, and a G-protein-coupled Receptor 30 agonist. Moreover, AATK expression is reduced in islets of insulin resistant animal models and selective silencing of AATK in INS832/13 cells by RNA interference promoted β-cell proliferation. The results point to a coordinated reduction of miR-338-3p and AATK under insulin resistance conditions and provide evidence for a cooperative action of the miRNA and its hosting gene in compensatory β-cell mass expansion.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25751313      PMCID: PMC5414744          DOI: 10.1210/me.2014-1299

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  41 in total

1.  A novel kinase, AATYK induces and promotes neuronal differentiation in a human neuroblastoma (SH-SY5Y) cell line.

Authors:  M Raghunath; R Patti; P Bannerman; C M Lee; S Baker; L N Sutton; P C Phillips; C Damodar Reddy
Journal:  Brain Res Mol Brain Res       Date:  2000-05-05

2.  Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance.

Authors:  Yasuo Terauchi; Iseki Takamoto; Naoto Kubota; Junji Matsui; Ryo Suzuki; Kajuro Komeda; Akemi Hara; Yukiyasu Toyoda; Ichitomo Miwa; Shinichi Aizawa; Shuichi Tsutsumi; Yoshiharu Tsubamoto; Shinji Hashimoto; Kazuhiro Eto; Akinobu Nakamura; Mitsuhiko Noda; Kazuyuki Tobe; Hiroyuki Aburatani; Ryozo Nagai; Takashi Kadowaki
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

3.  Intronic microRNA: discovery and biological implications.

Authors:  Sung-Chou Li; Petrus Tang; Wen-Chang Lin
Journal:  DNA Cell Biol       Date:  2007-04       Impact factor: 3.311

4.  MicroRNAs contribute to compensatory β cell expansion during pregnancy and obesity.

Authors:  Cécile Jacovetti; Amar Abderrahmani; Géraldine Parnaud; Jean-Christophe Jonas; Marie-Line Peyot; Marion Cornu; Ross Laybutt; Emmanuelle Meugnier; Sophie Rome; Bernard Thorens; Marc Prentki; Domenico Bosco; Romano Regazzi
Journal:  J Clin Invest       Date:  2012-09-10       Impact factor: 14.808

5.  Apoptosis-associated tyrosine kinase 1 inhibits growth and migration and promotes apoptosis in melanoma.

Authors:  Shuang Ma; Brian P Rubin
Journal:  Lab Invest       Date:  2014-03-03       Impact factor: 5.662

Review 6.  New insights into the role of cAMP in the production and function of the incretin hormone glucagon-like peptide-1 (GLP-1).

Authors:  Zhiwen Yu; Tianru Jin
Journal:  Cell Signal       Date:  2009-09-19       Impact factor: 4.315

7.  Mammalian microRNAs predominantly act to decrease target mRNA levels.

Authors:  Huili Guo; Nicholas T Ingolia; Jonathan S Weissman; David P Bartel
Journal:  Nature       Date:  2010-08-12       Impact factor: 49.962

8.  Structural and functional analysis of the apoptosis-associated tyrosine kinase (AATYK) family.

Authors:  M Tomomura; N Morita; F Yoshikawa; A Konishi; H Akiyama; T Furuichi; H Kamiguchi
Journal:  Neuroscience       Date:  2007-07-25       Impact factor: 3.590

9.  Beta-cell failure in diet-induced obese mice stratified according to body weight gain: secretory dysfunction and altered islet lipid metabolism without steatosis or reduced beta-cell mass.

Authors:  Marie-Line Peyot; Emilie Pepin; Julien Lamontagne; Martin G Latour; Bader Zarrouki; Roxane Lussier; Marco Pineda; Thomas L Jetton; S R Murthy Madiraju; Erik Joly; Marc Prentki
Journal:  Diabetes       Date:  2010-06-14       Impact factor: 9.461

10.  Features of mammalian microRNA promoters emerge from polymerase II chromatin immunoprecipitation data.

Authors:  David L Corcoran; Kusum V Pandit; Ben Gordon; Arindam Bhattacharjee; Naftali Kaminski; Panayiotis V Benos
Journal:  PLoS One       Date:  2009-04-23       Impact factor: 3.240

View more
  10 in total

1.  Exosomal Circular RNA hsa_circ_0046060 of Umbilical Cord Mesenchymal Stromal Cell Ameliorates Glucose Metabolism and Insulin Resistance in Gestational Diabetes Mellitus via the miR-338-3p/G6PC2 Axis.

Authors:  Minkai Cao; Chaozhi Bu; Jingjing Zhang; Yongwei Ren; Guanlun Zhou; Chao Chen; Guorong Han; Shi-Wen Jiang; Juan Wen
Journal:  Int J Endocrinol       Date:  2022-06-11       Impact factor: 2.803

Review 2.  Role of miRNAs in the pathogenesis of T2DM, insulin secretion, insulin resistance, and β cell dysfunction: the story so far.

Authors:  Prabhsimran Kaur; Sushil Kotru; Sandeep Singh; Bidwan Sekhar Behera; Anjana Munshi
Journal:  J Physiol Biochem       Date:  2020-08-04       Impact factor: 4.158

3.  Role of microRNAs in the age-associated decline of pancreatic beta cell function in rat islets.

Authors:  Ksenia Tugay; Claudiane Guay; Ana C Marques; Florent Allagnat; Jonathan M Locke; Lorna W Harries; Guy A Rutter; Romano Regazzi
Journal:  Diabetologia       Date:  2016-01       Impact factor: 10.122

Review 4.  MicroRNAs as stress regulators in pancreatic beta cells and diabetes.

Authors:  Mary P LaPierre; Markus Stoffel
Journal:  Mol Metab       Date:  2017-07-18       Impact factor: 7.422

5.  AAV-mediated pancreatic overexpression of Igf1 counteracts progression to autoimmune diabetes in mice.

Authors:  Cristina Mallol; Estefania Casana; Veronica Jimenez; Alba Casellas; Virginia Haurigot; Claudia Jambrina; Victor Sacristan; Meritxell Morró; Judith Agudo; Laia Vilà; Fatima Bosch
Journal:  Mol Metab       Date:  2017-05-17       Impact factor: 7.422

Review 6.  Noncoding RNAs Carried by Extracellular Vesicles in Endocrine Diseases.

Authors:  Margherita A C Pomatto; Chiara Gai; Maria Chiara Deregibus; Ciro Tetta; Giovanni Camussi
Journal:  Int J Endocrinol       Date:  2018-04-01       Impact factor: 3.257

7.  Circulating miR-338 Cluster activities on osteoblast differentiation: Potential Diagnostic and Therapeutic Targets for Postmenopausal Osteoporosis.

Authors:  Chujiao Lin; Shuaitong Yu; Runze Jin; Yao Xiao; Minghui Pan; Fei Pei; Xiaojing Zhu; Huarong Huang; Zunyi Zhang; Shuo Chen; Huan Liu; Zhi Chen
Journal:  Theranostics       Date:  2019-05-31       Impact factor: 11.556

Review 8.  Current treatment options and challenges in patients with Type 1 diabetes: Pharmacological, technical advances and future perspectives.

Authors:  Federico Boscari; Angelo Avogaro
Journal:  Rev Endocr Metab Disord       Date:  2021-03-23       Impact factor: 6.514

9.  Circular RNAs as novel regulators of β-cell functions in normal and disease conditions.

Authors:  Lisa Stoll; Jonathan Sobel; Adriana Rodriguez-Trejo; Claudiane Guay; Kailun Lee; Morten Trillingsgaard Venø; Jørgen Kjems; D Ross Laybutt; Romano Regazzi
Journal:  Mol Metab       Date:  2018-01-31       Impact factor: 7.422

10.  Predicting miRNA targets for hepatocellular carcinoma with an integrated method.

Authors:  Yi-Hua Shi; Tian-Fu Wen; De-Shuang Xiao; Ling-Bo Dai; Jun Song
Journal:  Transl Cancer Res       Date:  2020-03       Impact factor: 1.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.